Literature DB >> 20713627

CD4+ CD25+ Foxp3+ regulatory T cells, dendritic cells, and circulating cytokines in uncomplicated malaria: do different parasite species elicit similar host responses?

Raquel M Gonçalves1, Karina C Salmazi, Bianca A N Santos, Melissa S Bastos, Sandra C Rocha, Sílvia B Boscardin, Ariel M Silber, Esper G Kallás, Marcelo U Ferreira, Kézia K G Scopel.   

Abstract

Clearing blood-stage malaria parasites without inducing major host pathology requires a finely tuned balance between pro- and anti-inflammatory responses. The interplay between regulatory T (Treg) cells and dendritic cells (DCs) is one of the key determinants of this balance. Although experimental models have revealed various patterns of Treg cell expansion, DC maturation, and cytokine production according to the infecting malaria parasite species, no studies have compared all of these parameters in human infections with Plasmodium falciparum and P. vivax in the same setting of endemicity. Here we show that during uncomplicated acute malaria, both species induced a significant expansion of CD4(+) CD25(+) Foxp3(+) Treg cells expressing the key immunomodulatory molecule CTLA-4 and a significant increase in the proportion of DCs that were plasmacytoid (CD123(+)), with a decrease in the myeloid/plasmacytoid DC ratio. These changes were proportional to parasite loads but correlated neither with the intensity of clinical symptoms nor with circulating cytokine levels. One-third of P. vivax-infected patients, but no P. falciparum-infected subjects, showed impaired maturation of circulating DCs, with low surface expression of CD86. Although vivax malaria patients overall had a less inflammatory cytokine response, with a higher interleukin-10 (IL-10)/tumor necrosis factor alpha (TNF-α) ratio, this finding did not translate to milder clinical manifestations than those of falciparum malaria patients. We discuss the potential implications of these findings for species-specific pathogenesis and long-lasting protective immunity to malaria.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20713627      PMCID: PMC2976362          DOI: 10.1128/IAI.00578-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  53 in total

Review 1.  Immunobiology of dendritic cells.

Authors:  J Banchereau; F Briere; C Caux; J Davoust; S Lebecque; Y J Liu; B Pulendran; K Palucka
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster.

Authors: 
Journal:  Trans R Soc Trop Med Hyg       Date:  2000-04       Impact factor: 2.184

Review 3.  Dendritic-cell control of pathogen-driven T-cell polarization.

Authors:  Martien L Kapsenberg
Journal:  Nat Rev Immunol       Date:  2003-12       Impact factor: 53.106

4.  Low cellular response in vitro among subjects with long-term exposure to malaria transmission in Brazilian endemic areas.

Authors:  Erika M Braga; Luzia H Carvalho; Cor J F Fontes; Antoniana U Krettli
Journal:  Am J Trop Med Hyg       Date:  2002-03       Impact factor: 2.345

5.  Wide distribution of Plasmodium ovale in Myanmar.

Authors:  T T Win; K Lin; S Mizuno; M Zhou; Q Liu; M U Ferreira; I S Tantular; S Kojima; A Ishii; F Kawamoto
Journal:  Trop Med Int Health       Date:  2002-03       Impact factor: 2.622

6.  Peripheral blood dendritic cells in children with acute Plasmodium falciparum malaria.

Authors:  B C Urban; T Mwangi; A Ross; S Kinyanjui; M Mosobo; O Kai; B Lowe; K Marsh; D J Roberts
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

7.  Serum cytokine profiles in patients with Plasmodium vivax malaria: a comparison between those who presented with and without thrombocytopenia.

Authors:  J-W Park; S-H Park; J-S Yeom; A-J Huh; Y-K Cho; J-Y Ahn; G-S Min; G-Y Song; Y-A Kim; S-Y Ahn; S-Y Woo; B-E Lee; E-H Ha; H-S Han; K Yoo; J-Y Seoh
Journal:  Ann Trop Med Parasitol       Date:  2003-06

8.  Decrease of lymphoid dendritic cells in blood from malaria-infected pregnant women.

Authors:  Mamadou Diallo; Delphine Aldebert; Jean-Charles Moreau; Malick Ndiaye; Ronan Jambou
Journal:  Int J Parasitol       Date:  2008-06-04       Impact factor: 3.981

9.  Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway.

Authors:  Sathit Pichyangkul; Kosol Yongvanitchit; Utaiwan Kum-arb; Hiroaki Hemmi; Shizuo Akira; Arthur M Krieg; D Gray Heppner; V Ann Stewart; Hitoshi Hasegawa; Sornchai Looareesuwan; G Dennis Shanks; R Scott Miller
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

10.  Murine malaria is exacerbated by CTLA-4 blockade.

Authors:  Thomas Jacobs; Sebastian E B Graefe; Sonja Niknafs; Iris Gaworski; Bernhard Fleischer
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

View more
  39 in total

1.  Surface expression of inhibitory (CTLA-4) and stimulatory (OX40) receptors by CD4+ regulatory T cell subsets circulating in human malaria.

Authors:  Raquel M Gonçalves-Lopes; Nathália F Lima; Karina I Carvalho; Kézia K G Scopel; Esper G Kallás; Marcelo U Ferreira
Journal:  Microbes Infect       Date:  2016-06-16       Impact factor: 2.700

2.  Differential cellular recognition of antigens during acute Plasmodium falciparum and Plasmodium vivax malaria.

Authors:  Ervi Salwati; Gabriela Minigo; Tonia Woodberry; Kim A Piera; Harini D de Silva; Enny Kenangalem; Emiliana Tjitra; Ross L Coppel; Ric N Price; Nicholas M Anstey; Magdalena Plebanski
Journal:  J Infect Dis       Date:  2011-04-15       Impact factor: 5.226

3.  Early Immune Regulatory Changes in a Primary Controlled Human Plasmodium vivax Infection: CD1c+ Myeloid Dendritic Cell Maturation Arrest, Induction of the Kynurenine Pathway, and Regulatory T Cell Activation.

Authors:  Tonia Woodberry; Jessica R Loughland; Gabriela Minigo; Julie G Burel; Fiona H Amante; Kim A Piera; Yvette McNeil; Tsin W Yeo; Michael F Good; Denise L Doolan; Christian R Engwerda; James S McCarthy; Nicholas M Anstey
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

Review 4.  Monocyte-derived dendritic cells in malaria.

Authors:  Isabella C Hirako; Patrícia A Assis; Bruno Galvão-Filho; Andrew D Luster; Lis Rv Antonelli; Ricardo T Gazzinelli
Journal:  Curr Opin Microbiol       Date:  2019-09-19       Impact factor: 7.934

5.  Vitamin D inhibits the occurrence of experimental cerebral malaria in mice by suppressing the host inflammatory response.

Authors:  Xiyue He; Juan Yan; Xiaotong Zhu; Qinghui Wang; Wei Pang; Zanmei Qi; Meilian Wang; Enjie Luo; Daniel M Parker; Margherita T Cantorna; Liwang Cui; Yaming Cao
Journal:  J Immunol       Date:  2014-06-25       Impact factor: 5.422

Review 6.  T cell exhaustion in protozoan disease.

Authors:  Jason P Gigley; Rajarshi Bhadra; Magali M Moretto; Imtiaz A Khan
Journal:  Trends Parasitol       Date:  2012-07-24

7.  Cytokine balance in human malaria: does Plasmodium vivax elicit more inflammatory responses than Plasmodium falciparum?

Authors:  Raquel M Gonçalves; Kézia K G Scopel; Melissa S Bastos; Marcelo U Ferreira
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

8.  Neutrophil paralysis in Plasmodium vivax malaria.

Authors:  Fabiana Maria de Souza Leoratti; Silvia Cellone Trevelin; Fernando Queiroz Cunha; Bruno Coelho Rocha; Pedro Augusto Carvalho Costa; Humberto Doriguêtto Gravina; Mauro Shugiro Tada; Dhelio Batista Pereira; Douglas Taylor Golenbock; Lis Ribeiro do Valle Antonelli; Ricardo T Gazzinelli
Journal:  PLoS Negl Trop Dis       Date:  2012-06-26

Review 9.  Mechanisms underlying the induction of regulatory T cells and its relevance in the adaptive immune response in parasitic infections.

Authors:  Laura Adalid-Peralta; Gladis Fragoso; Agnes Fleury; Edda Sciutto
Journal:  Int J Biol Sci       Date:  2011-11-01       Impact factor: 6.580

10.  Immunity to malaria in Plasmodium vivax infection: a study in central China.

Authors:  Kulachart Jangpatarapongsa; Hui Xia; Qiang Fang; Kaiming Hu; Yuanying Yuan; Meiyu Peng; Qi Gao; Jetsumon Sattabongkot; Liwang Cui; Baiqing Li; Rachanee Udomsangpetch
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.